Valsartan

Articles · Medicine Compliance Aid Stability · Lactation Safety Information · New Medicines ·
108581009

Articles

Medicine Compliance Aid Stability

generic · Aurobindo Pharma-Milpharm Ltd

Aurobindo Pharma-Milpharm Ltd
generic
Capsules 40mg, 80mg, 160mg
A3 · Amber 3 · No stability data is available. There are theoretical concerns with use in CAs, which may be mitigated by risk minimisation.
Airtight container
Protect from moisture
Hygroscopic powder. Store in airtight containers at a temperature of 25 degrees.
9th November 2015

Lactation Safety Information

Captopril; Enalapril
(with appropriate infant monitoring)
No published evidence of safety
Monitor infants for hypotension
13th January 2017

New Medicines

Diovan · Hypertension in children aged 1 to 5 years

Information

Diovan
Licence extension / variation
Novartis
Novartis

Development and Regulatory status

Launched
Launched
None
October 2019
Oct 19 · Licence change approved for Diovan 3mg/ml oral solution to include treatment of hypertension in children aged 1 to 5 years (previously 6 to 17 years). The new indication is treatment of hypertension in children and adolescents 1 to less than 18 years of age [2].

Category

Angiotensin II antagonist
The prevalence of hypertension in children is increasing due to the rise in obesity in children. Based on the use of ≥95th percentile to define hypertension, it would be expected that the prevalence of hypertension would be approximately 5%. However, due to regression to the mean with repeated measures, the prevalence of hypertension is lower than 5% [1].
Hypertension in children aged 1 to 5 years
Oral